KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Other Non Operating Income (2023 - 2025)

Fulgent Genetics (FLGT) has disclosed Other Non Operating Income for 3 consecutive years, with $44000.0 as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 528.57% to $44000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $153000.0 through Dec 2025, down 72.33% year-over-year, with the annual reading at $153000.0 for FY2025, 72.73% down from the prior year.
  • Other Non Operating Income hit $44000.0 in Q4 2025 for Fulgent Genetics, up from -$5000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $544000.0 in Q3 2024 to a low of -$22000.0 in Q4 2023.
  • Historically, Other Non Operating Income has averaged $92800.0 across 3 years, with a median of $27500.0 in 2024.
  • Biggest YoY gain for Other Non Operating Income was 855.56% in 2025; the steepest drop was 100.92% in 2025.
  • Year by year, Other Non Operating Income stood at -$22000.0 in 2023, then surged by 131.82% to $7000.0 in 2024, then surged by 528.57% to $44000.0 in 2025.
  • Business Quant data shows Other Non Operating Income for FLGT at $44000.0 in Q4 2025, -$5000.0 in Q3 2025, and $46000.0 in Q2 2025.